Abstract: A method for applying a coating to a surface includes providing a sprayable liquid binding agent formed of first and second components, pumping the first and second components of the binding agent to a first dispensing device and combining the first and second components in the first dispensing device to form the binding agent. The method further includes spraying the binding agent from the first dispensing device on to a surface to be coated, providing a particulate medium, and spraying the particulate medium from a second dispensing device into the liquid spray of binding agent produced by the first dispensing device. The binding agent may coat the particulate medium and adhere it to the surface to form a coating thereon. An apparatus for performing the method is also described.

Abstract: A method for applying a coating to a surface comprising providing a sprayable liquid binding agent formed of first and second components, pumping the first and second components of the binding agent to a first dispensing device (13) and combining the first and second components in the first dispensing device (13) to form the binding agent. The method further comprises spraying the binding agent from the first dispensing device (13) on to a surface to be coated (32), providing a particulate medium, and spraying the particulate medium from a second dispensing device (37) into the liquid spray of binding agent produced by the first dispensing device (13). The binding agent coating the particulate medium and adhering it to the surface (32) to form a coating thereon. An apparatus for performing the method is also described.

Abstract: The present invention relates generally to mammalian ?-N-acetyglucosaminidase and to genetic sequences encoding same and to their use in the investigation, diagnosis and treatment of subjects suspected of or suffering from ?-N-acetyglucosaminidase deficiency.

Abstract: The present invention relates to a novel gene, a novel protein encoded by said gene, a mutated form of the gene and to diagnostic and therapeutic uses of the gene or a mutated form thereof. More specifically, the present invention relates to a novel gene defective in autoimmune polyendocrinopathy syndrome type I (APS I), also called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) (MIM No. 240,300).

Abstract: The present invention relates to a method for the diagnosis of a disease related to immune maturation and regulation of immune response towards self and nonself, comprising the steps of detecting in a biological specimen the presence of a DNA sequence comprising the sequence of SEQ ID NO:1.